Abstract: The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.

Abstract: Disclosed are polymers suitable for hydrophilically modifying the surface of porous fluoropolymer supports, for example, a copolymer of the formula: Also disclosed are a method of preparing the polymers, a method of hydrophilically modifying porous fluoropolymer supports, hydrophilic fluoropolymer porous membranes prepared from the polymers, and a method of filtering fluids through the porous membranes.

Abstract: Techniques for generating a real-time 3D position of one device relative another device are described herein. In one embodiment, a first device may be equipped with one or more transmitters and receivers to collect location information based on direct localized signal transmission between the first device and a second device. The first device may also be equipped with an accelerometer and/or digital compasses to assist in resolving ambiguous locations when the first device and the second device are not at an alignment position. Each device may transmit part or all of its collected location information to another device to assist in obtaining the relative location. Alternatively, a separate server may receive the location information from the devices and calculate the relative location of each device based on the received location information.

Abstract: Disclosed are copolymers suitable for hydrophilically modifying the surface of fluoropolymer membranes. An example of the copolymers is: Also disclosed are a method of preparing the copolymers, a method of hydrophilically modifying porous fluoropolymer supports, hydrophilic porous fluoropolymer membranes prepared from the copolymers, and a method of filtering fluids by the use of the hydrophilic porous fluoropolymer membranes.

Abstract: Disclosed are polymers suitable for hydrophilically modifying the surface of porous fluoropolymer supports, for example, a copolymer of the formula: Also disclosed are a method of preparing the polymers, a method of hydrophilically modifying porous fluoropolymer supports, hydrophilic fluoropolymer porous membranes prepared from the polymers, and a method of filtering fluids through the porous membranes.

Abstract: The present invention relates to a preparation method of ionic liquids, particularly to a one-step reaction method used for synthesizing quaternary ammonium compounds or quaternary phosphonium compounds. In the method, a nitrogenous or phosphorous compound, a proton compound, and a carbonate ester are added into a reactor simultaneously to synthesize corresponding the quaternary ammonium ionic liquid or the quaternary phosphonium ionic liquid through said one-step reaction, i.e., ‘one-pot method’ reaction, during which three reactants are involved. The present invention also provides a lithium ion secondary battery comprising the ionic liquid prepared by above-mentioned preparation method. The ionic liquid preparation method of the present invention can widen the choice range of raw materials needed when preparing ionic liquids, and further widen the synthesized ionic liquid species.

Abstract: The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.

Abstract: A passive cooling system for a reactor core of a large-scale pressurized water reactor nuclear power plant includes a shield building having an outer wall and a through air inlet arranged on an upper part of the outer wall, a water tank arranged at an upper part of the shield building, a cooling water distribution plate arranged above a top of a containment within the shield building, a spray pipe arranged at an inside of the top of the shield building and having a water inlet end and a water outlet end, wherein the water inlet end is connected to a bottom of the water tank and the water outlet end is extended to be above the cooling water distribution plate, and an air deflector arranged between the shield building and the containment and having an upper end connected to an inside of the top of the shield building.

Abstract: The present invention is directed to novel quinoline compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.

Abstract: The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.

Abstract: Disclosed are copolymers which are useful in hydrophilically modifying porous fluoropolymer supports. An example of the copolymers is: Also disclosed are a method of preparing such copolymers, a method of modifying porous fluoropolymer surfaces, and hydrophilic fluoropolymer porous membranes prepared therefrom. Also disclosed is a method of filtering fluids by the use of the hydrophilic fluoropolymer porous membranes.

Abstract: Disclosed are polymers suitable for hydrophilically modifying the surface of porous fluoropolymer supports, for example, a copolymer of the formula: Also disclosed are a method of preparing the polymers, a method of hydrophilically modifying porous fluoropolymer supports, hydrophilic fluoropolymer porous membranes prepared from the polymers, and a method of filtering fluids through the porous membranes.

Abstract: Disclosed are copolymers suitable for hydrophilically modifying the surface of fluoropolymer membranes. An example of the copolymers is: Also disclosed are a method of preparing the copolymers, a method of hydrophilically modifying porous fluoropolymer supports, hydrophilic porous fluoropolymer membranes prepared from the copolymers, and a method of filtering fluids by the use of the hydrophilic porous fluoropolymer membranes.

Abstract: The present invention is directed to novel substituted bicyclic aromatic compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.

Abstract: The present invention is directed to novel quinoline compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.

Abstract: The present invention is directed to novel quinoline compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.

Abstract: The present invention is directed to novel substituted bicyclic aromatic compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.

Abstract: A two-step pathway for preparing high pure quaternary phosphonium salts is disclosed. In the first step, hydrogen phosphide (PH3) or a higher phosphine reacts with a protonic compound to produce a phosphonium salt, which then reacts with a carbonic acid diester to produce a quaternary phosphonium salt in the second step. On one hand, hydrogen phosphide (PH3) and higher phosphines, including primary phosphines, secondary phosphines, and tertiary phosphines, after neutralization with protonic compound, become sufficiently reactive and can be alkylated by carbonic acid diester to form quaternary phosphonium cations. On the other hand, as an anion-exchange procedure is completely avoided, the process not only gives quaternary phosphonium salts of high purity, but also gives people freedom to design the cation and the anion of a quaternary phosphonium salt synchronously by choosing a preferred phosphine and a protonic compound that can supply a desired anion.

Abstract: The present invention is directed to novel substituted bicyclic aromatic compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.

Abstract: The present invention is directed to novel quinoline compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.